The Myeloma Crowd Research Initiative (MCRI) is a new approach to funding cancer research; combining the skill and knowledge of leading myeloma specialists with the patient perspective and supportive patient social communities to select and fund promising research projects in myeloma. Our goal is to find and fund a cure for multiple myeloma.  One[...]

  The Myeloma Crowd Research Initiative (MCRI) taps into the power of crowdsourcing and crowdfunding to find and fund the best ideas, research and clinical applications leading to new myeloma treatments or potential cures. Currently, the MCRI is funding three research projects:  Dr. Chung, MD, PhD – Creating an Immune System Signature Dr. Rodriguez, MD[...]

  The Myeloma Crowd Research Initiative (MCRI) taps into the power of crowdsourcing and crowdfunding to find and fund the best ideas, research and clinical applications leading to new myeloma treatments or potential cures. Currently, the MCRI is funding three research projects:  Dr. Chung, MD, PhD – Creating an Immune System Signature Dr. Rodriguez, MD[...]

  The Myeloma Crowd Research Initiative (MCRI) taps into the power of crowdsourcing and crowdfunding to find and fund the best ideas, research and clinical applications leading to new myeloma treatments or potential cures. Currently, the MCRI is funding three research projects:  Dr. Chung, MD, PhD – Creating an Immune System Signature Dr. Rodriguez, MD[...]

David Chung, MD, PhD Memorial Sloan Kettering Cancer Center Interview Date: November 19, 2018 Summary Why do some multiple myeloma patients relapse early after stem cell transplant while others stay in remission for many years? The patient’s immune system may be a key factor.   David Chung, MD, PhD of Memorial Sloan Kettering Cancer Center was[...]

  The first Myeloma Crowd Research Initiative (MCRI) successfully raised $500,000 for two immunotherapy research projects for high-risk myeloma (CAR T and T cell treatments). Now, the MCRI will fund research to match the right treatment with the right patient at the right time.  A small fraction of multiple myeloma patients may already be cured[...]

Monday, November 19, 2018 @ 10 am Pacific, 11 am Mountain, Noon Central, 1 pm Eastern Call In by Phone to Listen Live: (347) 637-2631 or Listen Live Via Computer Why do some multiple myeloma patients relapse early after stem cell transplant while others stay in remission for many years? The patient’s immune system may be[...]

In 2015 the Myeloma Crowd had a hypothesis: If patients collaborated with myeloma experts, we could accelerate a cure. Our dream has become a reality with the success of the first Myeloma Crowd Research Initiative (MCRI) campaign. Our recent announcement was shared here. The MCRI is the first patient-led crowdsourcing and crowdfunding initiative for multiple myeloma[...]

The Myeloma Crowd Initiative selected two proposals it has selected for the MCRI crowdsourcing and patient-led funding initiative. This is the first time that a united group of patients have joined with myeloma researchers to find and fund a cure for high-risk myeloma. “The study of high-risk myeloma should be one of the top priorities[...]

Richard Hite is a myeloma patient who can’t wait for a cure. Can you? Because only 1 in 12 research proposals are funded by the NCI, we decided that it was time patients pitch in to help speed a cure for themselves. It typically takes 10 years to bring a new treatment to the clinic.[...]